Amphastar Pharmaceuticals Inc
AMPH
Market Cap$1.22B
Close$
$46.17
77.7% upside
Current Fair Value
77.7% upsideUndervalued by 77.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.22 Billion |
|---|---|
| Enterprise Value | $1.70 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $3.29 |
| Beta | 0.76 |
| Outstanding Shares | 47,641,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 8.69 |
|---|---|
| PEG | -20.96 |
| Price to Sales | 1.73 |
| Price to Book Ratio | 1.73 |
| Enterprise Value to Revenue | 2.34 |
| Enterprise Value to EBIT | 8.52 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0.39 |
| Debt to Equity | 0.89 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Amphastar Pharmaceuticals Inc
CEO: Jack Zhang